SightfileU.S. market data from official filings
Companies › INMD
INMODE LTD (INMD)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001742692 · EDGAR filings · Updated 2026-07-20
INMODE LTD (INMD) has reported institutional ownership of 52.9%, with 192 institutional managers holding positions valued at $458.5M per the latest 13F reporting period.
Institutional ownership
52.9%
Institutional managers
192
Reported 13F value
$458.5M
Latest updates
- 2026-07-20 — Foreign issuer report (6-K) filed
- 2026-07-13 — Foreign issuer report (6-K) filed
- 2026-07-10 — Foreign issuer report (6-K) filed
- 2026-06-25 — Foreign issuer report (6-K) filed
- 2026-06-24 — SCHEDULE 13D/A filed
- 2026-06-24 — Foreign issuer report (6-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, INMODE LTD has 192 institutional holders and institutional ownership of 52.9%.
Insider activity
Insiders reported 0 transactions (0 buys, 0 sells) across 7 reporting insiders, with a net reported value of $0.
Related companies
AVALO THERAPEUTICS INC (AVTX) · CRESCENT BIOPHARMA INC. (CBIO) · LEXEO THERAPEUTICS INC (LXEO) · MIMEDX GROUP INC (MDXG) · ALLOGENE THERAPEUTICS INC (ALLO) · MANNKIND CORP (MNKD)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.